Spero Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Spero Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2016 to Q2 2024.
  • Spero Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 54M shares, a 2.73% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 54M +1.44M +2.73% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 53.9M +1.3M +2.47% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 53M +543K +1.04% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 53M +10.1M +23.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 52.6M +17.5M +49.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 52.6M +19.8M +60.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 52.5M +20.1M +61.9% Dec 31, 2022 10-K 2024-03-13
Q3 2022 42.9M +10.6M +33% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 35.1M +5.37M +18.1% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 32.8M +3.09M +10.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 32.4M +3.13M +10.7% Dec 31, 2021 10-K 2023-03-30
Q3 2021 32.2M +6.25M +24.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 29.7M +8.69M +41.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 29.7M +9.34M +45.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 29.3M +10.1M +52.5% Dec 31, 2020 10-K 2022-03-31
Q3 2020 26M +7.31M +39.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 21M +2.36M +12.7% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 20.3M +2.99M +17.3% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 19.2M +1.98M +11.5% Dec 31, 2019 10-K 2021-03-11
Q3 2019 18.7M +481K +2.64% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 18.7M +4.27M +29.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 17.3M +2.97M +20.6% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 17.2M +2.84M +19.7% Dec 31, 2018 10-K 2020-03-16
Q3 2018 18.2M +17.8M +5323% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 14.4M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 14.4M Mar 31, 2018 10-Q 2018-05-10
Q4 2017 14.4M +14.4M Dec 31, 2017 10-K 2019-03-14
Q3 2017 335K Sep 30, 2017 10-Q 2017-12-14
Q4 2016 0 Dec 31, 2016 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.